The macular leakage area in Vabysmo patients was more than 50% smaller compared to aflibercept at 16 weeks. Vabysmo reduced the macular leakage area to 3.6 mm2 from baseline compared to 7.6 mm2 ...

Central retinal artery occlusion (CRAO) is a sight‐threatening condition characterised by the abrupt interruption of blood flow to the retina. The resultant ischaemia precipitates sudden ...

Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels in retinal vascular diseasesSOUTH SAN FRANCISCO, Calif., May 02, 2022 (GLOBE ...

According to Saeedi, an analysis of more than 88,000 fundus images showed that women with glaucoma showed a “dramatic decline” in central retinal artery equivalent and central retinal vein ...

Researchers are planning future studies on HIF, the breakdown of the blood-retinal barrier and 32-134D, and hope to conduct clinical studies of 32-134D in patients with diabetic retinopathy.

Orally administered treatment was well tolerated, with early signs of clinical activity In models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against ...

Absence of retinal fluid, as measured by absence of SRF and IRF observed in 75% of patients in each treatment arm, occurred at eight weeks with Vabysmo versus 12 weeks with aflibercept, corresponding ...